A detailed history of Mtm Investment Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mtm Investment Management, LLC holds 10,794 shares of LLY stock, worth $8.96 Million. This represents 4.18% of its overall portfolio holdings.

Number of Shares
10,794
Previous 11,043 2.25%
Holding current value
$8.96 Million
Previous $8.59 Million 13.75%
% of portfolio
4.18%
Previous 3.69%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$724.87 - $909.04 $180,492 - $226,350
-249 Reduced 2.25%
10,794 $9.77 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $25,464 - $34,068
43 Added 0.39%
11,043 $8.59 Million
Q4 2023

Jan 16, 2024

BUY
$525.19 - $619.13 $525 - $619
1 Added 0.01%
11,000 $6.41 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $10,867 - $14,982
-25 Reduced 0.23%
10,999 $5.91 Million
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $350 - $468
1 Added 0.01%
11,024 $5.17 Million
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $310 - $364
1 Added 0.01%
11,023 $3.79 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $321 - $374
1 Added 0.01%
11,022 $4.03 Million
Q3 2022

Oct 27, 2022

BUY
$296.48 - $337.87 $296 - $337
1 Added 0.01%
11,021 $3.56 Million
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $9,755 - $11,454
35 Added 0.32%
11,020 $3.58 Million
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $29,805 - $37,040
127 Added 1.17%
10,985 $3.15 Million
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $6,520 - $8,092
-29 Reduced 0.27%
10,858 $3 Million
Q3 2021

Oct 22, 2021

SELL
$221.6 - $272.71 $680,090 - $836,946
-3,069 Reduced 21.99%
10,887 $2.52 Million
Q1 2021

Apr 19, 2021

BUY
$164.32 - $212.72 $164 - $212
1 Added 0.01%
13,956 $2.61 Million
Q4 2020

Jan 27, 2021

BUY
$130.46 - $172.63 $1.82 Million - $2.41 Million
13,955 New
13,955 $2.36 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mtm Investment Management, LLC Portfolio

Follow Mtm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mtm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mtm Investment Management, LLC with notifications on news.